BioSpace News Archive

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of the Washington State Department of Agriculture Fertilizer Registration Certificate for its mustard plant-based TerraSanteTM crop fertilizer and soil amendment product.

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company”) is pleased to announce it has completed the previously announced (see Press Release November 7, 2023) acquisition of all of the shares of Triniti Trading Corp. an authorized distributor of TonyMoly products in Canada (o/a TonyMoly Canada), a highly renowned beauty and skincare brand, on November 14, 2023.

CorMedix Inc. (Nasdaq: CRMD) today announced that the U.S. Food and Drug Administration (FDA) has approved DefenCath® (taurolidine and heparin) catheter lock solution (CLS) to reduce the incidence of catheter-related bloodstream infections (CRBSIs) for the limited population of adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC).

A new study published in Nature, conducted by the Accelerating Medicines Partnership, reports on the identification of new subtypes of rheumatoid arthritis by analyzing molecular patterns in biopsies from patient joints.

bioAffinity Technologies, Inc. today launched a campaign in partnership with the American Cancer Society (ACS) to increase lung cancer screening in Texas.

Halberd Corporation is in talks with Mississippi State University to extend its original six-month research arrangement by an additional two years, encompassing yet-to-be defined projects.

Orionis Biosciences today announced that the first patient has been dosed in a Phase 1 clinical trial of ORB-011, an attenuated, cis-targeted interferon immunotherapy based on the company’s A-Kine® platform.

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that USDA-APHIS’s Biotechnology Regulatory Services has determined that Yield10’s glufosinate tolerant Camelina sativa may be grown and bred in the United States.

Longhorn Vaccines and Diagnostics today presented new data from an animal study of LHNVD-301, the company’s lead tuberculosis vaccine candidate.

CNS Pharmaceuticals, Inc. today reported its financial results for the quarter ended September 30, 2023 and reiterated upcoming milestones.